| Followers | 303 |
| Posts | 4680 |
| Boards Moderated | 0 |
| Alias Born | 11/26/2009 |
Saturday, February 06, 2010 3:41:51 PM
General - I haven't gone through the filings (I will tonight once my kids go to sleep!), but I took a look at the Yahoo boards in the hope of "Cliff Notes" on the filings. There are actually some interesting exchanges going on with respect to these filings. Worth checking out. Obviously I take these postings with a grain of salt until I read the filings myself, but there is some intelligent banter going on over there.
Just my 0.02!
BTW - did you do anything with DDSS on the bounce off 2.00 last Thursday? I almost pulled the trigger and wish I had!! That bounce off 2.00 was nice. I still think DDSS retests 1.80's w/o news. We'll see.
Cheers!
Just my 0.02!
BTW - did you do anything with DDSS on the bounce off 2.00 last Thursday? I almost pulled the trigger and wish I had!! That bounce off 2.00 was nice. I still think DDSS retests 1.80's w/o news. We'll see.
Cheers!
Recent CLRB News
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 05/19/2026 09:05:41 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/18/2026 09:00:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/18/2026 08:15:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2026 11:20:27 AM
- Cellectar Biosciences Reports First Quarter 2026 Financial Results and Provides Corporate Updates • GlobeNewswire Inc. • 05/14/2026 11:15:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2026 11:00:55 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/12/2026 12:07:18 AM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 05/11/2026 11:05:22 PM
- Cellectar Biosciences to Report First Quarter Financial Results and Host a Conference Call on Thursday, May 14, 2026 • GlobeNewswire Inc. • 05/11/2026 12:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2026 10:04:31 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 05/06/2026 03:48:39 PM
- Cellectar (CLRB) Phase 2b Data Shows Durable Responses in Waldenström Macroglobulinemia • IH Market News • 05/05/2026 02:21:30 PM
- Cellectar Biosciences Reports Positive 12-Month Follow-Up Data from Phase 2b CLOVER WaM Study Demonstrating Durable Responses and Efficacy of Iopofosine I 131 in r/r Waldenström Macroglobulinemia • GlobeNewswire Inc. • 05/05/2026 11:10:00 AM
- Cellectar Biosciences Announces Oversubscribed Financing Up to $140 Million • GlobeNewswire Inc. • 05/05/2026 11:00:00 AM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 04/30/2026 08:51:51 PM
- Cellectar Biosciences Announces Subset of CLOVER WaM Clinical Trial Data Accepted for Presentation at the American Society of Clinical Oncology Conference 2026 • GlobeNewswire Inc. • 04/21/2026 02:00:00 PM
- Cellectar Enrolls First Patient in CLR 125 Auger-Emitting Radioconjugate Phase 1b Clinical Trial Targeting Refractory Triple Negative Breast Cancer (TNBC) • GlobeNewswire Inc. • 04/14/2026 12:35:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/04/2026 12:23:46 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/04/2026 12:21:32 PM
- Cellectar Biosciences Reports Financial Results for Year Ended 2025 and Provides Corporate Updates • GlobeNewswire Inc. • 03/04/2026 12:15:00 PM
- Cellectar Biosciences to Report Full Year Financial Results and Host a Conference Call on Wednesday, March 4, 2026 • GlobeNewswire Inc. • 02/25/2026 01:05:00 PM
- Cellectar Biosciences Expands Global Intellectual Property Estate • GlobeNewswire Inc. • 02/17/2026 01:05:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/13/2026 09:44:33 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/10/2026 08:23:12 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/04/2026 09:11:14 PM
